Rutgers, The State University of New Jersey
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rutgers, The State University of New Jersey sits in the top decile of US sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count).
Rutgers, The State University of New Jersey: 413 sponsored US clinical trials, 109 recruiting.
Rutgers, The State University of New Jersey sponsors 413 registered US clinical trials on ClinicalTrials.gov, 109 of them currently recruiting, and 196 completed. 35 of these trials are in Phase 3-4 (later-stage) and 104 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 6 trials.
Top-decile sponsor footprint
Rutgers, The State University of New Jersey ranks in the top decile of sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
196 of 267 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
413 total, page 7 of 9
Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
NCT02289989
Understanding the Role of the Anesthesiologist
NCT02566642
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
NCT02191748
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines
NCT02090998
How Much Can the Thoracic and Lumbar Skin Slide?
NCT02105363
Exparel and Ankle Surgery
NCT02072135
AML Therapy With Irradiated Allogeneic Cells
NCT02105116
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
NCT02688192
The Effect of Juice Types on the Responses to Air Pollution
NCT02027415
Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery
NCT03112642
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
NCT03233555
Acupuncture for Reduction of Inflammation
NCT01937520
Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells
NCT01993004
Tegaderm and Visual Evoked Potentials
NCT02105337
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer
NCT01828476
Guided Self-Help for Depression in Parkinson's Disease
NCT01935050
Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
NCT02144701
Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors
NCT01810640
High Dose Vitamin C in the Critically Ill Patient
NCT01587963
Patients With Positive Urine Cocaine Metabolites Undergoing General Anesthesia
NCT01788202
Obstructive Sleep Apnea in World Trade Center Responders
NCT01753999
Calcinosis in a Single-Center Scleroderma Population
NCT02062125
Comparing Palpation Guided and Ultrasound Guided Arterial Line Placement
NCT01757314
Novel Technique for Face Mask Ventilation
NCT01946464
Novel Psychosocial Influences on Smoking Cessation
NCT02173938
Persistence-Targeted Smoking Cessation
NCT01654107
Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance
NCT02421575
Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)
NCT01618539
Dose of Corticosteroids in COPD
NCT01742338
Analysis of Blood During Surgery for Musculoskeletal Tumors
NCT01682252
Optimal Neck Angle for Internal Jugular Cannulation
NCT02072889
Effect of Gabapentin on Orthopedic Pain
NCT01546857
The Effects of Epinephrine in Endotoxemia in Normal Volunteers
NCT00753402
Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
NCT01649947
Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells
NCT01587690
Methylselenocysteine Effects on Circadian Rhythm
NCT01611038
Developing a Smoking Cessation Intervention for Methadone Maintained Smokers
NCT01393392
Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children
NCT01431170
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
NCT01982058
MRI-Guided Laser Induced Thermal Therapy
NCT01515085
Use of Transesophageal Echocardiography to Measure Intraoperative Renal Resistive Index and Predict Acute Renal Injury
NCT01547065
Remote Ischemic Preconditioning in Neurological Death Organ Donors
NCT01515072
Improving The Safety And Nutritional Adequacy Of The Home Food Supply Of Elderly Recipients Of Home Delivered Meals
NCT02719626
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
NCT01009931
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
NCT01308736
Decisional Aid Intervention for Women Considering Breast Reconstruction
NCT01951534
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
NCT01417286
Comparing Implant Stability Using Two Accepted Techniques for Implant Sites
NCT02096978
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
NCT01407562
Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00962845
What is open in the Rutgers, The State University of New Jersey pipeline
109 recruiting of 413 indexed (26% open); 196 completed (47%).
Phase mix: 35 late (III/IV) vs 104 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rutgers, The State University of New Jersey: open-pipeline peers nationwide
Peers matched on 413 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Rutgers, The State University of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 413 trials (± recruiting share)
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
Sponsors near 26% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this Rutgers, The State University of New Jersey page
413 registered trials is a research-attention snapshot, not an endorsement of Rutgers, The State University of New Jersey or any single study.
- 109 of Rutgers, The State University of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Rutgers, The State University of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rutgers, The State University of New Jersey pipeline card: 413 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.